1015 Capital Partners’s Labcorp LH Stock Holding History

1015 Capital Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.08K	Hold	11	–	–	﹤0.01%	286
2026 Q1	$2.94K	Hold	11	–	–	﹤0.01%	281
2025 Q4	$2.76K	Buy	+11	New	+$2.92K	﹤0.01%	283

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

1015 Capital Partners's LH Position: Q2 2026 in Review

1015 Capital Partners held its Labcorp (LH) position steady in Q2 2026 at 11 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #286.

1015 Capital Partners first reported a position in LH in Q4 2025 and has held it in 3 quarters since. 1,049 funds tracked by Wall St. Rank hold LH as of Q2 2026.

1015 Capital Partners held 11 shares of Labcorp worth $3.08K as of Q2 2026.
1015 Capital Partners left its Labcorp share count unchanged in Q2 2026.
Labcorp made up ﹤0.01% of 1015 Capital Partners's portfolio in Q2 2026, its #286 holding.
1015 Capital Partners first reported a position in Labcorp in Q4 2025 and has held it in 3 quarters since.
1,049 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.